Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficiency and Tolerance of Rituximab (mabthéra) in Bullous Pemphigoid (Rituximab2)

This study has been completed.
Information provided by (Responsible Party):
University Hospital, Rouen Identifier:
First received: July 20, 2007
Last updated: September 5, 2014
Last verified: September 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)